1. Home
  2. ASMB vs PMVP Comparison

ASMB vs PMVP Comparison

Compare ASMB & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • PMVP
  • Stock Information
  • Founded
  • ASMB 2005
  • PMVP 2013
  • Country
  • ASMB United States
  • PMVP United States
  • Employees
  • ASMB N/A
  • PMVP N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • ASMB Health Care
  • PMVP Health Care
  • Exchange
  • ASMB Nasdaq
  • PMVP Nasdaq
  • Market Cap
  • ASMB 92.1M
  • PMVP 85.5M
  • IPO Year
  • ASMB 2010
  • PMVP 2020
  • Fundamental
  • Price
  • ASMB $14.03
  • PMVP $1.44
  • Analyst Decision
  • ASMB Buy
  • PMVP Strong Buy
  • Analyst Count
  • ASMB 2
  • PMVP 3
  • Target Price
  • ASMB $35.00
  • PMVP $5.33
  • AVG Volume (30 Days)
  • ASMB 22.8K
  • PMVP 161.2K
  • Earning Date
  • ASMB 03-27-2025
  • PMVP 02-27-2025
  • Dividend Yield
  • ASMB N/A
  • PMVP N/A
  • EPS Growth
  • ASMB N/A
  • PMVP N/A
  • EPS
  • ASMB N/A
  • PMVP N/A
  • Revenue
  • ASMB $28,326,000.00
  • PMVP N/A
  • Revenue This Year
  • ASMB $282.16
  • PMVP N/A
  • Revenue Next Year
  • ASMB N/A
  • PMVP N/A
  • P/E Ratio
  • ASMB N/A
  • PMVP N/A
  • Revenue Growth
  • ASMB N/A
  • PMVP N/A
  • 52 Week Low
  • ASMB $9.84
  • PMVP $1.32
  • 52 Week High
  • ASMB $19.93
  • PMVP $2.26
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 39.96
  • PMVP 49.20
  • Support Level
  • ASMB $13.76
  • PMVP $1.37
  • Resistance Level
  • ASMB $14.67
  • PMVP $1.46
  • Average True Range (ATR)
  • ASMB 0.72
  • PMVP 0.05
  • MACD
  • ASMB -0.09
  • PMVP 0.01
  • Stochastic Oscillator
  • ASMB 2.03
  • PMVP 85.71

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Share on Social Networks: